Skip to main content
TipRanks
Go Ultimate75% OFF

Mark J. Murray Insider Profile

4 Followers

Mark J. Murray, President & CEO, Director at Arbutus Biopharma, holds 341.40K shares in Arbutus Biopharma (Ticker: ABUS).

Mark J. Murray's Trading History

ABUS
Arbutus Biopharma
Nov 30, 2018President & CEO, DirectorUninformative Buy33.75K$1.40M
ABUS
Insider Shares: 341.40K (0.62%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 30, 2018Uninformative Buy$33.75K25,000$1.35―
Apr 17, 2018Uninformative Buy$9.45K27,007$0.35―
Jun 20, 2016Informative Buy$12.80K5,000$2.56+8.80%
Sep 15, 2015Informative Buy$96.55K219,428$0.44-45.60%
Dec 31, 2014Uninformative Buy―64,961$15.15―

You May Also Like

Mark J. Murray insider profile FAQ

What is the percentage of profitable transactions made by Mark J. Murray?
The percentage of profitable transactions made by Mark J. Murray is 50%.
What is the average return per transaction made by Mark J. Murray?
The average return per transaction made by Mark J. Murray is -18.40%.
What stocks does Mark J. Murray hold?
Mark J. Murray holds: ABUS stocks.
What was Mark J. Murray’s latest transaction?
Mark J. Murray’s latest transaction was an Uninformative Buy of $33.75K.
What was Mark J. Murray's most profitable transaction?
Mark J. Murray’s most profitable transaction was an Informative Buy of ABUS stock on June 20, 2016. The return on the trade was 8.80%.
What is Mark J. Murray's role in Arbutus Biopharma?
Mark J. Murray's role in Arbutus Biopharma is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.